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Prognostic value of nonlinear heart rate dynamics in hemodial-
ysis patients with coronary artery disease.
Background. Although altered nonlinear heart rate dynamics
predicts death in patients with coronary artery disease (CAD),
its prognostic value in chronic hemodialysis patients with CAD
is unknown.
Methods. We analyzed 24-hour electrocardiogram for non-
linear heart rate dynamics and heart rate variability in a retro-
spective cohort of 81 chronic hemodialysis patients with CAD.
Results. During a follow-up period of 31  20 months, 19
cardiac and 8 noncardiac deaths were observed. Cox hazards
model, including diabetes, left ventricular ejection fraction, and
the number of diseased coronary arteries, revealed that abnor-
mal 2 (defined as both increase and decrease in 2 because
of its J curve relationship with cardiac mortality), decreased
approximate entropy and decreased heart rate variability (tri-
angular index and ultra-low frequency power) were significant
and independent predictors of cardiac death. No significant
and independent predictive power for noncardiac death was
observed in either the heart rate dynamics or the heart rate
variability measures. The predictive power of 2 and approxi-
mate entropy was independent of that of triangular index and
ultra-low frequency power. Combinations of two categories of
measures improved the predictive accuracy; overall accuracy of
approximate entropy  ultra-low frequency power for cardiac
death was 87%.
Conclusion. Altered nonlinear heart rate dynamics are inde-
pendent predictors of cardiac death in chronic hemodialysis
patients with CAD and their combinations with decreased
heart rate variability provide clinically useful markers for risk
stratification.
Despite the recent progress in hemodialysis therapy,
mortality is high in patients with end-stage renal disease
(ESRD) on chronic hemodialysis. In these patients, the
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prevalence of coronary artery disease (CAD) is also high
[1] and their 5-year mortality rate is 80% [2]. Identifi-
cation of high-risk individuals is of apparent clinical im-
portance.
Decreased heart rate variability is an increased risk
for death in patients with CAD [3, 4] and we reported
that it predicts death in hemodialysis patients with CAD
[5]. However, it is increasingly clear that alterations in
nonlinear heart rate dynamics, which are not detected
by heart rate variability analysis, are more powerful pre-
dictors of death in patients with CAD [6, 7]. In the
present study, we therefore examined the prognostic
value of nonlinear heart rate dynamics as well as time-
and frequency-domain heart rate variability in chronic
hemodialysis patients with CAD.
METHODS
Patients
We studied retrospectively a cohort of 97 patients with
ESRD on regular hemodialysis therapy (a 4-hour hemo-
dialysis session, three times a week) who underwent an
elective coronary angiography between 1989 and 1996
for assessment of their CAD. All patients had symptoms
and/or clinical signs of CAD, including typical anginal pain,
positive exercise electrocardiogram (ECG), and previous
history of myocardial infarction. Patients were excluded
if they had any of the following: an episode of acute myocar-
dial infarction, stroke or major surgical procedure within
2 months, hemodynamically significant valvular or con-
genital heart disease, atrial fibrillation or flutter, high-
grade heart block, permanent pacemaker implantation,
chronic obstructive lung disease, severe hepatic disease,
malignant neoplasm, or other physical or mental prob-
lems limiting their physical activities. All subjects gave
their informed consent to participate in the study and
the study protocol was approved by Institutional Review
Board of Nagoya City University Medical School.
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Protocols
Before the index hospitalization for angiography, pa-
tients underwent a 24-hour Holter ECG (DMC-3253;
Nihon Koden, Tokyo, Japan) between hemodialysis ses-
sions under their usual daily activities. They underwent
coronary and left ventricular cine angiography and were
subsequently followed up by cardiologists every week
after return to outpatient regular hemodialysis therapy.
Data analysis
The blood chemistry, chest roentgenogram, and echo-
cardiogram obtained during or within a month before the
hospitalization were used for assessing baseline clinical
features. Diabetes was defined by the presence of dia-
betic nephropathy, use of insulin or oral hypoglycemic
agents, or casual plasma blood glucose 200 mg/dL; dys-
lipidemia by use of lipid-lowering agents, total choles-
terol 220 mg/dL, or high-density lipoprotein choles-
terol40 mg/dL; hypertension controlled by regular use
of antihypertensive drugs; left ventricular hypertrophy
identified by end-diastolic thickness of the posterior wall
plus that of the ventricular septum25 mm on the echo-
cardiogram; and macrovascular disease by atherosclero-
sis obliterance of peripheral arteries or aortic stenosis/
aneurysm. Diseased coronary artery was defined as ma-
jor epicardial artery with 75% or more stenosis on the
angiogram. Left ventricular ejection fraction was mea-
sured by the angiography.
The end point of this study was death, which was
classified into cardiac death (myocardial infarction, car-
diac failure, and sudden cardiac death) and noncardiac
death. Sudden cardiac death was defined as unexpected
death within 1 hour after the onset of a new symptom,
or unexpected unwatched death.
Analysis of Holter ECG
Holter ECG was digitized to 12-bit data at 128 Hz
with a scanner (DMC-4100; Nihon Koden), on which
QRS complexes were detected and labeled automati-
cally. Results of the automatic analysis were reviewed
and any errors in R wave detection and in QRS labeling
were edited manually. Recordings with a total analyzable
length of 231⁄2 hours were excluded from this study.
According to the edited QRS labeling, patients with fre-
quent ventricular and supra-ventricular ectopic beats
10% of total recorded beats were also excluded.
Normal-to-normal R-R interval data obtained from
the edited time sequence of R wave and QRS labeling
were transferred to a Microsoft Windows–based personal
computer (Dimension 8200; Dell, Austin, TX, USA).
For the assessment of nonlinear heart rate dynamics, 24-
hour data were divided into segments with a length of
8000 beats, according to the earlier report [6]. In each
segment, short-term (4 to 11 beats, 1) and long-term
(11 beats, 2) scaling exponents were assessed by de-
trended fluctuation analysis [8] and approximate entropy
[9] was computed with a parameter set of N  8000, m 
2, and r  20% of SD. These measures were averaged
over all segments during 24 hours. For time-domain heart
rate variability, mean normal-to-normal R-R intervals,
standard deviation of normal-to-normal R-R intervals
and triangular index [10] were calculated. For frequency-
domain heart rate variability, power spectrum was com-
puted by fast Fourier transformation and natural log-
transformed powers of high, low, very-low, and ultra-
low frequency bands were calculated by the standard
method [11]. The computations were performed with a
custom-made FORTRAN 77 program. Subroutine source
codes of the detrended fluctuation analysis were ob-
tained from a Web site (http://reylab.bidmc.harvard.edu/
download/DFA/intro/) and those for approximate en-
tropy were developed based on a literature [9].
Statistical analysis
We used a SAS program package (SAS Institute, Cary,
NC, USA) for all statistical analysis. Cox proportional
hazards regression was used for assessing relative risks
(RR) for death of baseline clinical features and heart
rate dynamics and heart rate variability measures. The
cut-off points for each quantitative measure were deter-
mined as maximizing RR for cardiac death. The indepen-
dent predictive power of heart rate dynamics and heart
rate variability measures was determined by multivariate
Cox hazards model, including all clinical variables with
a significant univariate association. Survival curves were
calculated by Kaplan-Meier method and the differences
between curves were evaluated with log-rank tests. Prog-
nostic value of measures and their combinations was also
evaluated with positive, negative, and overall predictive
accuracy. Differences in quantitative and categoric data
were compared by the Student tests and the Fisher’s
exact probability tests, respectively. Quantitative data
were presented as the mean  SD, and risk for death
was expressed as RR with the 95% CI. P  0.05 was
considered significant.
RESULTS
Survival during follow-up
The baseline data were obtained from 97 patients, in
whom ten and six patients were excluded because of
atrial fibrillation and frequent ectopic beats, respectively.
Consequently, the number of patients participated in the
follow-up study was 81, which included all patients (N 
31) of our preliminary study [5]. The follow-up survey
of the 31 patients and remaining 50 patients was per-
formed in May 1997 and May 2000, respectively.
During a follow-up period for 31 20 [median (range),
27 (1 to 67)] months, 27 patients (33%) died; 19 died
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Table 1. Baseline clinical features of patients grouped by survival
Survivor Cardiac death Noncardiac
(N  54) (N  19) death (N  8)
Age years 597.7 637.5 6210
Male number (%) 37 (69) 13 (68) 5 (63)
Duration of hemodialysis years 8.47.4 7.56.0 7.45.0
Diabetes mellitus number (%) 14 (26) 10 (53)a 5 (63)a
Previous myocardial infarction number (%) 10 (19) 5 (26) 2 (25)
Current smoking number (%) 22 (41) 5 (26) 3 (38)
Dyslipidemia number (%) 21 (39) 10 (53) 6 (75)
Total cholesterol mg/dL 16631 17830 15734
High-density lipoprotein cholesterol mg/dL 399.4 366.7 3812
Hypertension number (%) 37 (69) 12 (63) 6 (75)
Hematocrit % 303.8 292.4 272.6a
Macrovascular disease number (%) 4 (7) 4 (21) 2 (25)
Cardiothoracic ratio 50% number (%) 17 (31) 9 (47) 2 (25)
Left ventricular hypertrophy number (%) 25 (46) 13 (68) 6 (75)
Left ventricular ejection fraction % 6812 5512b 5519b
Diseased coronary arteries number 0.90.9 1.51.2a 0.60.5
Lown’s grade 4 arrhythmia number (%) 3 (6) 3 (16) 2 (25)
Medications
Calcium channel antagonists number (%) 28 (52) 11 (58) 4 (50)
Angiotensin-converting enzyme inhibitors number (%) 11 (20) 5 (26) 3 (38)
Beta-blockers number (%) 8 (15) 0 (0) 0 (0)
Coronary revascularization during follow-up
Coronary angioplasty number (%) 16 (30) 9 (47) 2 (25)
Coronary artery bypass graft surgery number (%) 4 (7) 1 (5) 0 (0)
Data represent meanSD or frequency (within-group percentage).
aP  0.05 vs. survivor; bP  0.01
from cardiac causes (nine from sudden cardiac death,
seven from progressive congestive heart failure, and
three from acute myocardial infarction) and eight from
noncardiac causes (three from infection, two from a ma-
lignancy, one from an aortic dissection, one from a
stroke, and one from an accident). The survival duration
for the nonsurvivors was 22  13 [22 (1 to 45)] months.
Baseline clinical features and therapies during follow-up
Compared with the surviving patients, those who died
from cardiac causes were more likely to have diabetes
mellitus, were lower in left ventricular ejection fraction,
and were greater in the number of diseased coronary
arteries (Table 1). There was no difference in medica-
tions at baseline.
During the follow-up, none of the patient underwent
renal transplantation. Coronary angioplasty and/or coro-
nary bypass graft surgery were performed in 20 (37%)
survivors and in 12 (45%) nonsurvivors; the frequency
did not differ with the survival state (Table 1).
Heart rate dynamics and heart rate variability
Analyses of nonlinear heart rate dynamics and heart
rate variability in representative patients are shown in
Figure 1 and mean values of the measures in patients
grouped by survival are shown in Table 2. Among nonlin-
ear heart rate dynamics measures, approximate entropy
tended to be lower in patients who died from cardiac
causes than in the surviving patients (P  0.13). As
the mean values, neither 1 nor 2 showed significant
difference with the survival state. Among heart rate vari-
ability measures, ultra-low frequency power was lower
in patients who died from cardiac causes than in the
surviving patients. Triangular index was lower in patients
who died from either cardiac or noncardiac cause than
in the surviving patients.
Survival analysis
Among baseline clinical features, significant univariate
predictive power for cardiac death was observed in dia-
betes mellitus [RR (95% CI), 2.5 (1.0 to 6.2)], left ventric-
ular ejection fraction [1.1 (1.0 to 1.1) per 1% decrement]
and the number of diseased coronary arteries [1.8 (1.1
to 2.8) per artery]. Also, significant univariate predictive
power for noncardiac death was observed in hematocrit
[1.4 (1.1 to 1.8) per 1% decrement].
Nonlinear heart rate dynamics measures
Considering possible nonlinear prognostic associa-
tions of nonlinear heart rate dynamics measures, we ex-
amined the incidence of death with dividing the patients
into quintiles by each measure. As shown in Figure 2,
there were J curve relationships between 2 and inci-
dences of cardiac death, although no such relationships
were observed for 1 or approximate entropy. Conse-
quently, we defined both increase and decrease in 2 as
abnormal (potential risk for death), while only decreases
in1 and approximate entropy were defined as abnormal.
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Fig. 1. Trendgrams (top), histograms (mid-
dle), and power spectra (bottom) of 24-hour
R-R intervals and detrended fluctuation anal-
ysis of 8000 R-R intervals. Panels on the left
were data from a male patient who survived
during a follow-up for 42 months. Panels on
the right were data from a male patient who
died suddenly 2 months after the measure-
ment. Abbreviations are: SDNN, standard de-
viation of normal-to-normal R-R intervals;
ApEn, approximate entrophy; TI, triangular
index; HF, high frequency power; LF, low fre-
quency power; VLF, very-low frequency
power; ULF, ultra-low frequency power.
Univariate Cox regression analysis revealed that 2
had the maximum predictive power for cardiac death,
when abnormal 2 was defined 2 as 1.09 or 1.20.
Also, approximate entropy showed the maximum pre-
dictive power for cardiac death with a cut-off value of
0.77, although no significant predictive power was de-
tected for 1. The predictive power of abnormal 2 and
decreased approximate entropy, thus defined, was signifi-
cant for cardiac death and was also significant even after
adjustment for other univariate predictors (Table 3). No
significant predictive power for noncardiac death was ob-
served in the heart rate dynamics measures. No significant
difference was observed in the frequency of coronary revas-
cularization therapy during the follow-up between the pa-
tients with normal and abnormal2 or between the patients
with and without decreased approximate entropy. Figure
3 shows survival curves for cardiac death in patients
stratified by 2 and approximate entropy.
Heart rate variability measures
The predictive power of triangular index and ultra-
low frequency power for cardiac death was significant
and independent of those of the other univariate pre-
dictors (Table 3). When the patients were dichotomized
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Table 2. Nonlinear heart rate dynamics and heart rate variability
measures in patients grouped by survival
Survivor Cardiac death Noncardiac
(N  54) (N  19) death (N 8)
1 1.070.29 1.020.28 0.940.34
2 1.140.07 1.170.10 1.180.15
ApEn 0.930.18 0.810.31 0.820.21
Mean NN mseconds 845135 809150 78793
SDNN mseconds 95.729.5 80.327.9 97.140.2
TI 25.68.9 20.27.9a 18.96.9b
ln HF [ln(ms2)] 3.981.14 4.011.25 3.331.15
ln LF [ln(ms2)] 4.541.15 4.461.63 3.701.89
ln VLF [ln(ms2)] 6.090.96 6.111.10 5.621.98
ln ULF [ln(ms2)] 8.740.69 8.350.68b 8.451.37
Abbreviations are: 1 and 2 indicate short-term and long-term scaling expo-
nents; ApEn, approximate entropy; NN, normal-to-normal R-R intervals; SDNN,
standard deviation of normal-to-normal R-R intervals; TI, triangular index; HF,
high frequency power; LF, low frequency power; VLF, very-low frequency power;
ULF, ultra-low frequency power.
Data represent meanSD.
aP  0.01; bP  0.05 vs. survivor
by triangular index (at 21.5) and ultra-low frequency
power [at 8.47 ln (ms2)], significant predictive power for
cardiac death was observed in decreased triangular index
and ultra-low frequency power even after adjustment
for other univariate predictors. Although significant pre-
dictive power for noncardiac death was observed in de-
creased triangular index, the predictive power did not
remain significant after adjustment for hematocrit. No
significant difference was observed in the frequency of
coronary revascularization therapy during the follow-up
between patients dichotomized by triangular index and
ultra-low frequency power. Figure 3 shows survival
curves for cardiac death in patients dichotomized by
triangular index and ultra-low frequency power.
Predictive accuracy
The combinations of nonlinear heart rate dynamics
and heart rate variability measures improved overall pre-
dictive accuracy for cardiac death (Table 4). The pre-
dictive power of the nonlinear measures of heart rate
dynamics was independent of that of the heart rate vari-
ability measures; the RRs (95% CI) of 2 and approxi-
mate entropy adjusted for both triangular index and ul-
tra-low frequency power were 9.9 (2.3 to 43) and 4.3 (1.7
to 11) for cardiac death, respectively. Consequently, the
combinations of nonlinear heart rate dynamics and heart
rate variability measures improved the positive pre-
dictive accuracy without disproportionately decreasing
the negative predictive accuracy. The best overall pre-
dictive accuracy for cardiac death was obtained by ap-
proximate entropy  ultra-low frequency power (87%).
DISCUSSION
Major findings
We examined prognostic value of nonlinear heart rate
dynamics and heart rate variability measures in chronic
hemodialysis patients with CAD. We demonstrated that
both increase and decrease in long-term scaling exponent
(2), decrease in irregularity/complexity of heart rate dy-
namics (approximate entropy), and decreases in long-term
heart rate variability (triangular index and ultra-low fre-
quency power) are independent predictors for cardiac
death but not for noncardiac death and that the combina-
tions of two categories of measures provide a predictive
accuracy much greater than that obtained by each single
measure. The present study indicates that altered nonlin-
ear heart rate dynamics and decreased heart rate vari-
ability, particularly the combinations of the two, provide
clinically useful noninvasive markers for risk stratifica-
tion in chronic hemodialysis patients with CAD.
Prognostic value of heart rate variability measures
Although many studies reported prognostic value of
heart rate variability in patients with CAD [3, 4], there is
only our preliminary report for the value in hemodialysis
patients with CAD [5]. In the preliminary study, we found
that decreased triangular index (22) was the most pow-
erful predictor of death; but, the sample size (N  31)
of the study was too small to draw a definite conclusion.
In the present study, we confirmed the prognostic value
of triangular index and also of ultra-low frequency
power. We observed, however, that the heart rate vari-
ability measures have only moderate prognostic value.
Prognostic value of nonlinear measures of heart
rate dynamics
Recently, evidence is accumulated for prognostic value
of altered nonlinear heart rate dynamics. A decrease in
short-term scaling exponent (1) of heart rate dynamics
is a powerful predictor of death/fatal arrhythmic event
in postmyocardial infarction patients [6, 7], patients with
congestive heart failure [12], and recipients of implantable
cardioverter defibrillators [13]. A decrease in approxi-
mate entropy is an increased risk for cardiac death in
patients with chronic atrial fibrillation [14].
Besides the study population, the present study is
unique from the earlier studies in its novel findings about
prognostic value of nonlinear heart rate dynamics. First,
we demonstrated J curve relationships of long-term scal-
ing exponent (2) with risks for cardiac death. Second,
short-term scaling exponent (1) had no significant pre-
dictive power; this is discordant with the earlier studies
reporting that decreased 1 is a more powerful predictor
of adverse prognosis than increased 2 [6, 7, 12, 13]. Third,
decreased approximate entropy was also a predictor of
death; to our knowledge, this is the first study reporting
significant predictive value of approximate entropy of
heart rate dynamics in patients with sinus rhythm [13].
To consider possible mechanisms for our observations,
it may be useful to look over the mathematic and physio-
logic features of the measures of nonlinear dynamics.
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Fig. 2. Incidence of cardiac death in patients
divided into quintiles by nonlinear measures
of heart rate dynamics [1,2 and approximate
entropy (ApEn)]. Ranges of 1st, 2nd, 3rd, 4th,
and 5th quintiles by 1 are 0.35 to 0.78, 0.80
to 0.94, 0.96 to 1.10, 1.11 to 1.33, and 1.34 to
1.63, respectively. Ranges of 1st, 2nd, 3rd, 4th,
and 5th quintile by 2 are 0.90 to 1.08, 1.08 to
1.11, 1.12 to 1.17, 1.17 to 1.21, and 1.22 to 1.41,
respectively. Ranges of 1st, 2nd, 3rd, 4th, and
5th quintile by approximate entropy are 0.40
to 0.69, 0.71 to 0.79, 0.80 to 0.94, 0.94 to 1.07,
and 1.07 to 1.50, respectively.
Table 3. Univariate and adjusted relative risks (RR) of nonlinear
heart rate dynamics and heart rate variability measures by Cox
proportional hazards regression analysis
Cardiac death
Univariate Adjusteda
1 0.95 (N  32)b 1.2 (0.5–3.0) 1.4 (0.5–3.4)
21.09 or1.20 (N39) 11 (2.4–46)c 11 (2.4–46)c
ApEn 0.77 (N  25) 4.0 (1.6–10)c 3.9 (1.4–11)c
SDNN 79 (N  26) 1.8 (0.7–4.5) 2.1 (0.8–5.2)
Mean NN 880 (N  59) 5.1 (0.7–38) 4.7 (0.6–35)
TI 21.5 (N  40) 3.5 (1.3–9.9)d 3.7 (1.3–11)d
ln HF 3.15 (N  21) 1.2 (0.4–3.3) 1.1 (0.4–3.0)
ln LF 3.60 (N  23) 1.7 (0.7–4.6) 2.0 (0.6–6.2)
ln VLF 5.94 (N  35) 1.1 (0.4–2.8) 1.3 (0.5–3.3)
ln ULF 8.47 (N  34) 2.9 (1.1–7.4)d 2.9 (1.1–7.6)d
Abbreviations are: 1 and 2 indicate short-term and long-term scaling expo-
nents; ApEn, approximate entropy; NN, normal-to-normal R-R intervals; SDNN,
standard deviation of normal-to-normal R-R intervals; TI, triangular index; HF,
high frequency power; LF, low frequency power; VLF, very-low frequency power;
ULF, ultra-low frequency power.
Data are RR (95% CI).
aAdjusted for diabetes mellitus, left ventricular ejection fraction, and the
number of diseased coronary arteries
bCut-off value(s) (number of patients); cP  0.01; dP  0.05.
The scaling exponent reflects the degree of correlation
existing within time series data; low (0.5), middle (1.0),
and high (1.5) scaling exponent indicates white noise-
like random fluctuation with no correlation, fractal noise-
like fluctuation with long-range correlations, and Brown-
ian noise-like fluctuation with short-range correlations,
respectively [15]. Although heart rate dynamic is known
to exhibit a scaling exponent close to 1, it has two differ-
ent exponents, 1 and 2, for short-term (4 to 11 beats)
and long-term (11 beats) scaling regions, respectively.
Based on the time scale of dynamics, 1 is thought to reflect
primarily autonomic and respiratory influences on heart
rate dynamics, whereas 2 reflects also endocrine, meta-
bolic processes, volume shifts, and other influences [15].
Approximate entropy is a measure of complexity/irreg-
ularity of signal [9]. Theoretically, it decreases with an
increase in short-range correlation (an increase in the
scaling exponent toward 1.5) and, partly, with an increase
in overall magnitude of fluctuation.
From these aspects, two possible mechanisms may un-
derlie the relationships between altered nonlinear heart
rate dynamics and an increased mortality rate in hemodi-
alysis patients with CAD. The predictive powers of in-
creased 2 and decreased approximate entropy may be
attributable to a loss of flexibility/complexity of long-term
regulatory systems, while the increased mortality in patients
with decreased 2 may result from decreased regulatory
power of the system. Because hemodialysis therapy causes
rapid volume shift of body fluid, the capability to control
body fluid distribution is critical to these patients to adapt
to the therapy. If such regulatory systems have limited
flexibility or a narrow control capacity, small water reten-
tion may easily cause congestive heart failure and small
excess in water removal velocity may cause intradialysis
hypotension. Both could lead exaggerated sympathetic
stimulations and other neurohumoral activations, which
may cause myocardial ischemia, precipitate fatal arrhyth-
mia, and facilitate cardiovascular remodeling. Other
mechanisms, including cardiovascular autonomic dys-
functions, seem also important. The improvement of pre-
dictive accuracy with combinations of nonlinear heart
rate dynamics and heart rate variability measures may
suggest involvement of multiple mechanisms.
Study limitations
We have to consider several limitations. First, tempo-
ral stability of nonlinear heart rate dynamics and heart
rate variability measures in hemodialysis patients has
not been established. There is much evidence, however,
for stability of heart rate variability in nonhemodialysis
patients with CAD and nonlinear heart rate dynamics
has been reported to be more stable than heart rate
variability [18]. Additionally, we measured ECG on the
day between hemodialysis sessions to avoid the possible
influences of hemodialysis session on heart rate variabil-
ity [16, 17]. Second, we needed to exclude the patients
with frequent ectopic beats or atrial fibrillation, which
are not a few among this population. However, this is
the inherent limitation of analysis of heart rate dynamics
and heart rate variability. Third, the follow-up survey of
the 31 patients of our previous study was performed at
the different time from that of remaining 50 patients.
However, our results were substantially unchanged even
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Fig. 3. Kaplan-Meier survival curves for car-
diac death in patients divided by nonlinear
measures of heart rate dynamics [2 and ap-
proximate entropy (ApEn)] and heart rate vari-
ability measures [triangular index (TI) and
ultra-low frequency power (ULF)]. Normal 2
is defined as 1.09 to 1.20. Abnormal 2 is de-
fined as 1.09 or 1.20.
Table 4. Predictive accuracy of nonlinear heart rate dynamics and
heart rate variability measures
Cardiac death
Positive Negative Overall
predictive predictive predictive
accuracy % accuracy % accuracy %
2 1.09 or 1.20 (N  39) 44 95 70
ApEn 0.77 (N  25) 44 86 65
TI 21.5 (N  40) 35 88 61
ln ULF 8.47 (N  34) 35 85 60
21.09 or1.20 TI21.5
(N  22) 59 90 75
ApEn 0.77  TI 21.5
(N  16) 63 86 74
2 1.09 or 1.20 
ln ULF 8.47 (N  18) 61 87 74
ApEn0.77 ln ULF8.47
(N  9) 89 85 87
Abbreviations are: 2 indicates short-term and long-term scaling exponents;
ApEn, approximate entropy; TI, triangular index; ULF, ultra-low frequency
power.
after excluding the 31 patients. Finally, we cannot ex-
clude the possibility that abnormal electrolytes triggered
serious arrhythmia and caused sudden cardiac death.
However, the routine laboratory data obtained from the
patients who died suddenly showed no evidence for an
abnormal level of electrolyte.
Clinical implications
Despite recent progress in hemodialysis therapy, prog-
nosis of the patients, particularly of those with CAD is
poor [2]. Establishing a new clinical tool for identifying
high-risk patients is pressing demand. The present study
demonstrated that altered nonlinear heart rate dynamics
in combination with decreased heart rate variability have
clinically acceptable levels of positive and negative pre-
dictive accuracy for cardiac death during a long-term
follow-up. Analysis of nonlinear heart rate dynamics and
heart rate variability seems a unique and clinically useful
approach to risk stratification in hemodialysis patients
with CAD.
Our data indicate that the predictive value of nonlin-
ear heart rate dynamics and heart rate variability is inde-
pendent of diabetes in hemodialysis patients with CAD.
Diabetes is a possible cause of decreased heart rate vari-
ability in hemodialysis patients [19]. Diabetes also is an
established risk for death in hemodialysis patients [20].
We observed, however, that the predictive value of non-
linear heart rate dynamics and heart rate variability re-
mained significant even after adjustment for diabetes.
The prognostic association of altered nonlinear heart
rate dynamics and decreased heart rate variability may
be independent of diabetes at least in this population.
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Beta-blockers tend to be seldom prescribed to hemo-
dialysis patients in Japan. In fact, only eight patients
among the survivors and none of cardiac death patients
were on beta-blockers at baseline in our study. Increasing
use of beta-blockers seems important in high-risk patients,
given that beta-blockers could improve altered nonlinear
heart rate dynamics in cardiac patients [21].
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